X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9) 9
index medicus (9) 9
article (8) 8
animals (6) 6
hiv-1 - immunology (6) 6
human immunodeficiency virus--hiv (6) 6
immunology (6) 6
female (5) 5
hiv infection (5) 5
immunoglobulins (5) 5
mice (5) 5
therapy (5) 5
adult (4) 4
antiviral agents (4) 4
broadly neutralizing antibodies (4) 4
drug therapy (4) 4
hiv infections - immunology (4) 4
hiv infections - virology (4) 4
male (4) 4
middle aged (4) 4
monoclonal-antibodies (4) 4
multidisciplinary sciences (4) 4
potent (4) 4
t-cells (4) 4
viremia (4) 4
viruses (4) 4
young adult (4) 4
antibodies (3) 3
antibodies, neutralizing - administration & dosage (3) 3
antibodies, neutralizing - immunology (3) 3
antiretroviral drugs (3) 3
antiretroviral therapy (3) 3
binding sites (3) 3
cell biology (3) 3
cell line (3) 3
dendritic cells - immunology (3) 3
fibrin (3) 3
health aspects (3) 3
hiv antibodies (3) 3
hiv antibodies - administration & dosage (3) 3
hiv antibodies - immunology (3) 3
immunotherapy (3) 3
infections (3) 3
medicine, research & experimental (3) 3
passive transfer (3) 3
physiological aspects (3) 3
virology (3) 3
adolescent (2) 2
aged (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal - immunology (2) 2
antibodies, monoclonal - pharmacokinetics (2) 2
antibodies, neutralizing - pharmacology (2) 2
antibodies, neutralizing - therapeutic use (2) 2
antiretroviral agents (2) 2
care and treatment (2) 2
cattle (2) 2
cd4 antigens - metabolism (2) 2
clinical trials (2) 2
dc-sign (2) 2
dendritic cells - virology (2) 2
drug therapy, combination (2) 2
durable control (2) 2
endothelial-cells (2) 2
env gene products, human immunodeficiency virus - genetics (2) 2
fibrinogen - chemistry (2) 2
fibrinopeptides (2) 2
flt3l (2) 2
genetic-determinants (2) 2
haptides (2) 2
hiv antibodies - pharmacology (2) 2
hiv antibodies - therapeutic use (2) 2
hiv envelope protein gp120 - immunology (2) 2
hiv infections - blood (2) 2
hiv infections - drug therapy (2) 2
hiv-1 - drug effects (2) 2
hiv-1 - genetics (2) 2
human immunodeficiency virus (2) 2
humanized mice (2) 2
immunodeficiency-virus type-1 (2) 2
in-vivo (2) 2
infection (2) 2
infusion (2) 2
lectins, c-type - immunology (2) 2
lymphocyte culture test, mixed (2) 2
methods (2) 2
mice, inbred balb c (2) 2
mice, inbred c57bl (2) 2
monoclonal antibodies (2) 2
monoclonal-antibody (2) 2
neutralizing (2) 2
pharmacology (2) 2
poly ic (2) 2
prevention (2) 2
rats (2) 2
receptors (2) 2
receptors, cell surface - immunology (2) 2
sequence (2) 2
t-lymphocytes - virology (2) 2
time factors (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 06/2015, Volume 522, Issue 7557, pp. 487 - 491
HIV-1 immunotherapy with a combination of first generation monoclonal antibodies was largely ineffective in pre-clinical and clinical settings and was... 
THERAPY | VIRUS | HIV-1 NEUTRALIZATION | GENETIC-DETERMINANTS | IMMUNOTHERAPY | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | IN-VIVO | VACCINE | MICE | MONOCLONAL-ANTIBODIES | Antibodies, Neutralizing - administration & dosage | Humans | Middle Aged | Viremia - therapy | Molecular Sequence Data | Antibodies, Monoclonal - therapeutic use | Male | Case-Control Studies | HIV Envelope Protein gp120 - immunology | Young Adult | HIV Infections - immunology | Antibodies, Neutralizing - immunology | HIV Antibodies - adverse effects | HIV Antibodies - immunology | Time Factors | HIV-1 - chemistry | Antibodies, Neutralizing - therapeutic use | Adult | Antibodies, Neutralizing - adverse effects | Female | HIV Antibodies - therapeutic use | HIV Envelope Protein gp120 - chemistry | HIV Antibodies - pharmacology | Binding Sites | Antibodies, Monoclonal - immunology | Amino Acid Sequence | Immunization, Passive - methods | HIV-1 - drug effects | HIV Infections - virology | Antibodies, Monoclonal - pharmacokinetics | Antibodies, Neutralizing - pharmacology | HIV Antibodies - administration & dosage | Viral Load - immunology | HIV-1 - immunology | Viremia - virology | Antibodies, Monoclonal - administration & dosage | HIV Infections - therapy | Viremia - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Evolution, Molecular | Viral antibodies | Virus diseases | Physiological aspects | Antibodies | HIV infection | Antigens | Immunoglobulins | Human immunodeficiency virus--HIV | Immunotherapy | Infections | Drug dosages | Binding sites | Immune system
Journal Article
Nature, ISSN 0028-0836, 07/2016, Volume 535, Issue 7613, pp. 556 - 560
Interruption of combination antiretroviral therapy in HIV-1-infected individuals leads to rapid viral rebound. Here we report the results of a phase IIa open... 
POTENT | REPLICATION | GENETIC-DETERMINANTS | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | SEQUENCE | CD4 BINDING | ANTIRETROVIRAL THERAPY | INFECTION | MONOCLONAL-ANTIBODIES | Anti-HIV Agents - pharmacology | Antibodies, Neutralizing - administration & dosage | Disease Reservoirs - virology | Humans | Middle Aged | Male | Proviruses - immunology | Anti-HIV Agents - administration & dosage | Tissue Distribution | Young Adult | HIV Infections - immunology | Proviruses - drug effects | Antibodies, Neutralizing - immunology | HIV-1 - growth & development | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | Time Factors | Antibodies, Neutralizing - therapeutic use | Binding Sites - immunology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Antibodies - therapeutic use | Historically Controlled Study | Binding Sites - drug effects | HIV Envelope Protein gp160 - metabolism | Drug Administration Schedule | HIV-1 - drug effects | HIV Infections - virology | HIV Antibodies - administration & dosage | Viral Load - immunology | Proviruses - growth & development | HIV-1 - immunology | HIV Envelope Protein gp160 - antagonists & inhibitors | Adolescent | HIV Infections - drug therapy | Aged | HIV Envelope Protein gp160 - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Prevention | Antiviral agents | HIV antibodies | Dosage and administration | Host-virus relationships | Drug therapy, Combination | Drug therapy | Health aspects | HIV infection | Methods | Clinical trials | Antiretroviral drugs | Immunoglobulins | Human immunodeficiency virus--HIV | Binding sites
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2017, Volume 23, Issue 2, pp. 185 - 191
Journal Article
Nature, ISSN 0028-0836, 09/2018, Volume 561, Issue 7724, pp. 479 - 484
Journal Article
Nature Medicine, ISSN 1078-8956, 11/2018, Volume 24, Issue 11, pp. 1701 - 1707
Journal Article
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 11/2011, Volume 208, Issue 12, pp. 2357 - 2366
Journal Article
Journal Article
Journal of Experimental Medicine, ISSN 0022-1007, 2018, Volume 215, Issue 9, pp. 2311 - 2324
A clinical trial was performed to evaluate 3BNC117, a potent anti-HIV-1 antibody, in infected individuals during suppressive antiretroviral therapy and... 
MEDICINE, RESEARCH & EXPERIMENTAL | RECOMBINATION | CELLS | POTENT | BROADLY NEUTRALIZING ANTIBODIES | REVERSE-TRANSCRIPTASE | SEQUENCE | INFECTION | HIV-1 RESERVOIR | IMMUNOLOGY | MONOCLONAL-ANTIBODIES | COMBINATION | 312
Journal Article
The Journal of Immunology, ISSN 0022-1767, 10/2005, Volume 175, Issue 7, pp. 4265 - 4273
Journal Article